↓ Skip to main content

Plasmodium vivax: who cares?

Overview of attention for article published in Malaria Journal, December 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

1 blog


122 Dimensions

Readers on

206 Mendeley
Plasmodium vivax: who cares?
Published in
Malaria Journal, December 2008
DOI 10.1186/1475-2875-7-s1-s9
Pubmed ID

Mary R Galinski, John W Barnwell


More attention is being focused on malaria today than any time since the world's last efforts to achieve eradication over 40 years ago. The global community is now discussing strategies aimed at dramatically reducing malarial disease burden and the eventual eradication of all types of malaria, everywhere. As a consequence, Plasmodium vivax, which has long been neglected and mistakenly considered inconsequential, is now entering into the strategic debates taking place on malaria epidemiology and control, drug resistance, pathogenesis and vaccines. Thus, contrary to the past, the malaria research community is becoming more aware and concerned about the widespread spectrum of illness and death caused by up to a couple of hundred million cases of vivax malaria each year. This review brings these issues to light and provides an overview of P. vivax vaccine development, then and now. Progress had been slow, given inherent research challenges and minimal support in the past, but prospects are looking better for making headway in the next few years. P. vivax, known to invade the youngest red blood cells, the reticulocytes, presents a strong challenge towards developing a reliable long-term culture system to facilitate needed research. The P. vivax genome was published recently, and vivax researchers now need to coordinate efforts to discover new vaccine candidates, establish new vaccine approaches, capitalize on non-human primate models for testing, and investigate the unique biological features of P. vivax, including the elusive P. vivax hypnozoites. Comparative studies on both P. falciparum and P. vivax in many areas of research will be essential to eradicate malaria. And to this end, the education and training of future generations of dedicated "malariologists" to advance our knowledge, understanding and the development of new interventions against each of the malaria species infecting humans also will be essential.

Mendeley readers

The data shown below were compiled from readership statistics for 206 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 1%
Brazil 3 1%
United Kingdom 2 <1%
India 2 <1%
Germany 1 <1%
Indonesia 1 <1%
Colombia 1 <1%
Switzerland 1 <1%
Belgium 1 <1%
Other 3 1%
Unknown 188 91%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 47 23%
Researcher 33 16%
Student > Master 31 15%
Student > Bachelor 18 9%
Student > Postgraduate 14 7%
Other 35 17%
Unknown 28 14%
Readers by discipline Count As %
Agricultural and Biological Sciences 77 37%
Medicine and Dentistry 43 21%
Biochemistry, Genetics and Molecular Biology 16 8%
Immunology and Microbiology 14 7%
Computer Science 5 2%
Other 17 8%
Unknown 34 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2010.
All research outputs
of 22,708,120 outputs
Outputs from Malaria Journal
of 5,545 outputs
Outputs of similar age
of 164,838 outputs
Outputs of similar age from Malaria Journal
of 31 outputs
Altmetric has tracked 22,708,120 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,545 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,838 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.